Michael S. Cuffe Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 6 days, 4 hours ago
Michael S. Cuffe has an estimated net worth of at least $24.6 million*, as of Sept. 3, 2025. They own 31,502 shares of HCA stock. They have sold 42,361 shares of HCA stock since 2021, for an estimated $11.9 million.
Michael S. Cuffe $HCA SEC Form 4 Insider Trading
Michael S. Cuffe has filed a total of 8 insider trades in $HCA since 2021. Their most recent trade was a sale of 3,836 shares, made on Sep 08, 2025. Their largest trade was a sale of 12,556 shares, made on Apr 28, 2023. We estimate that they now own 31,502 shares of $HCA, worth an estimated $12.7 million.
Insider Trading at $HCA
There have been a total of 130 insider trades reported at $HCA since 2021, with 95,131 shares purchased and 520,485 shares sold. The most active insider traders in $HCA stock have been Kathryn A. Torres, Kathleen M Whalen, and Michael S. Cuffe. The most recent trade was a sale of 3,836 shares reported by Michael S. Cuffe (EVP and Chief Clinical Officer), made on Sep 08, 2025.
History of Insider Stock Trades by Michael S. Cuffe
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
HCA
|
Sale | 3,836 | Sep 08, 2025 | Sept. 8, 2025, 6:37 p.m. |
|
HCA
|
Sale | 8,358 | Sep 12, 2024 | Sept. 12, 2024, 5:21 p.m. |
|
HCA
|
Sale | 6,311 | May 09, 2024 | May 13, 2024, 5:08 p.m. |
|
HCA
|
Sale | 1,600 | May 06, 2024 | May 8, 2024, 5:43 p.m. |
|
HCA
|
Sale | 3,200 | Jan 31, 2024 | Feb. 2, 2024, 7:38 p.m. |
|
HCA
|
Sale | 12,556 | Apr 28, 2023 | May 2, 2023, 5:30 p.m. |
|
HCA
|
Sale | 4,000 | Feb 01, 2023 | Feb. 1, 2023, 8:57 p.m. |
|
HCA
|
Sale | 2,500 | Aug 03, 2021 | Aug. 4, 2021, 8 p.m. |
$HCA Executives and Stock Owners with Insider Trades
-
Kathryn A. Torres, SVP-Payer Contracting & Align.
-
Kathleen M Whalen, SVP & Chief Ethics Officer
-
Michael S. Cuffe, EVP and Chief Clinical Officer
-
Charles J Hall, Group President
-
P. Martin Paslick, SVP and CIO
-
Jane D. Englebright, SVP and Chief Nursing Officer
-
Jonathan B Perlin, Pres-Clinical Operations & CMO
-
Christopher F. Wyatt, SVP & Controller
-
Jennifer Berres, SVP & Chief Human Res. Officer
-
Bill B Rutherford, CFO and EVP
-
Joseph A Iii Sowell, SVP; Chief Development Officer
-
Samuel N Hazen, CEO
-
Phillip G Billington, SVP-Internal Audit Services
-
A Bruce Jr Moore, Group President - Service Line
-
Jon M Foster, Group President
-
Erol R Akdamar, Group President
-
Deborah M Reiner, SVP - Mktg. & Communications
-
Chad J Wasserman, SVP and CIO
-
Jon M Foster, EVP and COO
-
Jeffrey E. Cohen, SVP-Government Relations
-
Timothy M Mcmanus, Group President
-
Michael R Mcalevey, SVP & Chief Legal Officer
-
Michael S. Cuffe, President-Physician Services
-
Sammie S Mosier, SVP & Chief Nurse Executive
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.